Agios pharmaceuticals, inc. (AGIO)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Revenues:
Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Total revenue

174,783

117,912

112,485

101,659

115,852

94,387

74,173

70,333

41,265

43,011

0

37,817

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Cost and expenses:
Cost of sales

1,516

1,317

1,732

2,034

1,731

1,397

695

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

406,565

410,894

398,455

379,344

358,685

341,324

324,731

315,087

308,173

292,681

280,143

267,869

238,857

220,163

192,418

167,803

153,422

141,827

139,756

129,254

115,407

100,371

80,788

70,065

60,447

54,502

49,021

44,681

0

0

0

Selling, general and administrative

138,744

132,034

129,058

127,143

121,386

114,145

105,000

91,354

80,851

71,124

63,790

58,186

54,700

50,714

45,517

43,590

39,875

35,992

32,311

27,550

22,786

19,120

16,326

13,694

11,365

9,929

7,802

7,216

0

0

0

Total cost and expenses

546,825

544,245

529,245

508,521

481,802

456,866

430,426

406,441

389,024

363,805

343,933

326,055

293,557

270,877

237,935

211,393

193,297

177,819

172,067

156,804

138,193

119,491

97,114

83,759

71,812

64,431

56,823

51,897

0

0

0

Loss from operations

-372,042

-426,333

-416,760

-406,862

-365,950

-362,479

-356,253

-336,108

-347,759

-320,794

-288,073

-272,568

-244,438

-200,985

-184,473

-161,436

-137,099

-118,700

-104,530

-60,847

-47,044

-54,133

-39,648

-53,925

-44,121

-38,883

-31,751

-26,805

0

0

0

Interest income, net

13,392

14,861

15,844

17,455

17,669

16,451

13,734

11,116

8,430

6,124

5,202

4,000

2,999

2,514

1,867

1,407

1,126

968

777

607

405

203

147

112

83

55

39

48

0

0

0

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-38,828

-31,712

-26,757

0

0

0

Benefit from income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

579

-42

-751

0

0

0

Net loss

-358,650

-411,472

-400,916

-389,407

-348,281

-346,028

-342,519

-324,992

-339,329

-314,670

-282,871

-268,568

-241,439

-198,471

-182,606

-160,029

-135,973

-117,732

-103,775

-59,814

-46,213

-53,504

-39,222

-54,103

-44,427

-39,407

-31,670

-26,006

0

0

0

Cumulative preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,162

2,364

3,595

0

0

0

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-43,569

-34,034

-29,601

0

0

0

Net loss per share – basic and diluted (in usd per share)

-0.59

-1.59

-1.81

-1.87

-1.59

-1.58

-1.63

-1.19

-1.63

-1.82

-1.59

-1.78

-1.56

-1.36

-1.63

-1.47

-0.61

-1.10

-1.07

-0.85

-0.13

-

-

-0.54

-0.39

-

-

-2.80

-2.47

-0.83

-2.18

Weighted-average number of common shares used in computing net loss per share – basic and diluted (in usd per share)

68,608

63,998

58,803

58,722

58,453

58,223

58,033

57,721

55,694

48,864

48,459

46,745

42,280

42,136

38,548

37,956

37,864

37,665

37,507

37,329

37,214

-

-

33,602

31,394

-

-

3,722

3,658

3,439

3,358

Net income (loss) per share - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.11

-

-

-

-0.52

-

-

-

-

Net income (loss) per share - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.10

-

-

-

-0.52

-

-

-

-

Weighted-average number of common shares used in net income (loss) per share - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,495

-

-

-

22,744

-

-

-

-

Weighted-average number of common shares used in net income (loss) per share - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36,592

-

-

-

22,744

-

-

-

-

Product revenue, net
Total revenue

73,387

59,851

49,579

36,679

22,979

13,841

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue – related party
Total revenue

81,435

39,257

50,597

53,813

71,235

60,661

0

52,966

37,911

41,074

0

0

0

-

0

-

56,198

59,119

67,537

95,957

91,149

65,358

57,466

29,834

27,691

25,548

0

0

0

-

-

Collaboration revenue – other
Total revenue

8,285

8,262

2,432

2,012

13,640

12,670

0

12,440

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Royalty revenue – related party
Total revenue

11,676

10,542

9,793

9,128

7,998

7,215

0

4,927

3,354

1,937

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-